Anebulo Pharmaceuticals (ANEB.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov14

Anebulo Pharmaceuticals released FY2026 Q1 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0525 (forecast USD -0.12)

04:00

Nov13

Anebulo Pharmaceuticals Inc. Receives NIH Funding for Research on Cannabis-Induced Toxicity in Children

21:06

Oct1

Anebulo Pharmaceuticals Advances Research on Cannabis Toxicity Treatment Drug

06:57

Sep30

Anebulo Pharmaceuticals released FY2025 Annual Earnings on September 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2508 (forecast USD -0.285)

03:00

Anebulo Pharmaceuticals released FY2025 Q4 earnings on September 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0522 (forecast USD -0.065)

03:00

May15

Maxim Group Maintains Buy Rating for Anebulo Pharmaceuticals But Cuts Price Target to $3.00

17:32